To further validate that the expression of HOXD10 was regulated by promoter region methylation, HCC cells were treated with the DNA methylation transferase inhibitor, 5-aza-2′-deoxycytidine (5-aza). This evidence concerns the gene HOXD10 and hepatocellular carcinoma.